EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Real‐world effectiveness and safety of the LAight‐therapy in patients with hidradenitis suppurativa

Alexandra Strobel iD, Michael Schultheis, Petra Staubach, Stephan Grabbe, Caroline Mann iD, Katharina Hennig, Jacek C Szepietowski, Lukasz Matusiak, Piotr Krajewski, Esther von Stebut, Simone Garcovich, Hans Bayer und 4 weitere

JDDG: Journal der Deutschen Dermatologischen Gesellschaft · 2024

DOI: 10.1111/ddg.15403 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JDDG: Journal der Deutschen Dermatologischen Gesellschaft, 2024. Verfasst von Alexandra Strobel und 15 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Medical Epidemiology, Biostatistics, and Informatics, Faculty of Medicine, Martin-Luther-University Halle-Wittenberg, Halle/Saale, Germa…. Hauptthemen laut MEDLINE: Hidradenitis Suppurativa, Quality of Life. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: LENICURA GmbH.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and objectives Hidradenitis suppurativa (HS)/Acne inversa (Ai) is a chronic debilitating disease with limited therapy options. The device‐based LAight therapy was approved in Europe in 2017. The aim of this study was to evaluate the effect of real‐world care with at least one treatment with LAight therapy on disease activity and burden in 3,437 patients. Patients and Methods Patients were included in the analysis if they had a diagnosis of HS and received at least one treatment. The endpoints Hidradenitis Suppurativa Severity Score System (IHS4), pain on the numeric rating scale (pain‐NRS) and Dermatology Life Quality Index (DLQI) were analyzed using a linear mixed model for repeated measures (MMRM) over 26 weeks of care with LAight therapy. Furthermore, responder rates were calculated for all endpoints, and the therapy's safety profile and patient satisfaction were thoroughly examined.

Results

A significant decrease in IHS4, pain‐NRS, and DLQI was achieved during 26 weeks of care with LAight. The BMI at baseline had a significant negative effect on therapy response for pain‐NRS and DLQI.

Conclusions

This study confirms that LAight therapy leads to satisfactory disease control in all stages of severity and is a valuable addition to the therapeutic repertoire of HS.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hidradenitis SuppurativaQuality of LifeHumansMaleFemaleAdultTreatment OutcomePatient SatisfactionSeverity of Illness IndexMiddle AgedPain Measurement

Stichwörter der Autor:innen

acne inversahidradenitis suppurativalaight‐therapyoutpatient setting

Autor:innen und Institutionen

  • Institute of Medical Epidemiology, Biostatistics, and Informatics, Faculty of Medicine, Martin-Luther-University Halle-Wittenberg, Halle/Saale, Germany.
  • Profile Centre of Health Sciences Halle, Faculty of Medicine, Martin-Luther-University Halle-Wittenberg, Halle/Saale, Germany.
  • Dept. of Dermatology, University Medical Center, Johannes Gutenberg, University, Mainz, Germany.
  • Department of Dermatology, Venereology and Allergology, Wroclaw Medical University, Wroclaw, Poland.
  • Department of Dermatology, Faculty of Medicine, University of Cologne, Cologne, Germany.
  • Dermatology Outpatient Office Dr. Simone Garcovich, Rome, Italy.

ORCID-Profile: Alexandra Strobel, Caroline Mann

Förderung

  • LENICURA GmbH

Zitieren

APA

Strobel, A., Schultheis, M., Staubach, P., Grabbe, S., Mann, C., Hennig, K., Szepietowski, J. C., Matusiak, L., Krajewski, P., von Stebut, E., Garcovich, S., Bayer, H., Heise, M., Podda, M., Kirschner, U., & Nikolakis, G. (2024). Real‐world effectiveness and safety of the LAight‐therapy in patients with hidradenitis suppurativa. JDDG: Journal der Deutschen Dermatologischen Gesellschaft. https://doi.org/10.1111/ddg.15403

Vancouver

Strobel A, Schultheis M, Staubach P, Grabbe S, Mann C, Hennig K, et al. Real‐world effectiveness and safety of the LAight‐therapy in patients with hidradenitis suppurativa. JDDG: Journal der Deutschen Dermatologischen Gesellschaft. 2024. doi:10.1111/ddg.15403

BibTeX
@article{Strobel2024,
  author = {Strobel, Alexandra and Schultheis, Michael and Staubach, Petra and Grabbe, Stephan and Mann, Caroline and Hennig, Katharina and Szepietowski, Jacek C and Matusiak, Lukasz and Krajewski, Piotr and von Stebut, Esther and Garcovich, Simone and Bayer, Hans and Heise, Marcus and Podda, Maurizio and Kirschner, Uwe and Nikolakis, Georgios},
  title = {Real‐world effectiveness and safety of the LAight‐therapy in patients with hidradenitis suppurativa},
  journal = {JDDG: Journal der Deutschen Dermatologischen Gesellschaft},
  year = {2024},
  doi = {10.1111/ddg.15403}
}
Kostenlos starten →